Sorafenib in Patients With Hepatopulmonary Syndrome: A Double-Blind Randomized Clinical Trial
Phase of Trial: Phase II
Latest Information Update: 19 Mar 2018
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver disorders; Lung disorders
- Focus Therapeutic Use
- Acronyms SHPS
- 14 Mar 2018 Status changed from recruiting to discontinued.
- 05 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 05 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.